Prosecution Insights
Last updated: April 19, 2026

Dyve Biosciences Inc.

4 pending office actions

Portfolio Summary

4
Total Pending OAs
0
Final Rejections
4
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18351192 TRANSDERMAL PENETRANT FORMULATIONS FOR ADMINISTRATION OF MEDICAMENTS MOU, LIYUAN 1628 Non-Final OA Jul 12, 2023
17817774 TOPICAL DELIVERY OF BUFFERING AGENTS FOR PREVENTION AND TREATMENT OF VIRAL INFECTIONS KETCHAM, KAREN A 1614 Non-Final OA Aug 05, 2022
17839323 TOPICAL CYCLOSPORINE FOR TREATING PSORIASIS AND OTHER AILMENTS COFFA, SERGIO 1658 Non-Final OA Jun 13, 2022
17830236 TRANSDERMAL PENETRATION BY MODULATING EPITHELIAL JUNCTIONS BARBER, KIMBERLY 1615 Non-Final OA Jun 01, 2022

Managing Dyve Biosciences Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month